Parkinson’s disease is a chronic and progressive condition affecting the brain and nervous system. It impacts millions of ...

The following column was originally published on Feb. 25, 2022. Thanks to breakthroughs in medicine and nutrition in recent years, we are living longer than ever before. But this increase in life ...

I have long held the belief that digital therapeutics will be prescribed alongside drugs to improve patient outcomes, leading ...

HenriHenri David, 75, has lived for 42 years with Parkinson’s disease. There is no known cure for the ... Over the years, ...

Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, ...

The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), Alzheimer's, and Parkinson's disease continues to rise, especially for MS ...

Multiple courses of penicillin antibiotics were linked to a slightly lower risk of Parkinson's disease, according to a new ...

Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.

The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), ...

To learn more about cost trends in prescription medications for neurologic conditions ... 54,676 with MS, and 45,909 with ...

Geroscience has a long way to go, but there are four FDA-approved drugs that have shown promise to “target the process of ...